Reports for MYLAN PHARMACEUTICALS ULC
Company Name
MYLAN PHARMACEUTICALS ULC
Shortage reports
Actual shortage:
20 (3%)
Anticipated shortage:
6 (1%)
Avoided shortage:
88 (12%)
Resolved:
604 (84%)
718
Discontinuation Reports
To be discontinued:
0 (0%)
Discontinued:
235 (100%)
Reversed:
0 (0%)
235
89 (9%)
19 (73%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| FREYA 28 | 0.15MG 0.03MG | TABLET | Resolved | 2019-04-03 | 2019-07-03 | 80441 |
| FREYA 28 | 0.15MG 0.03MG | TABLET | Resolved | 2022-10-11 | 2022-10-31 | 171501 |
| FULVESTRANT INJECTION | 50MG | SOLUTION | Avoided shortage | 2020-10-21 | 2020-11-10 | 126796 |
| FULVESTRANT INJECTION | 50MG | SOLUTION | Resolved | 2021-01-05 | 2021-12-22 | 130857 |
| FULVESTRANT INJECTION | 50MG | SOLUTION | Avoided shortage | 2020-07-02 | 2020-08-17 | 119319 |
| GD-AMLODIPINE/ATORVASTATIN | 5MG 10MG | TABLET | Resolved | 2017-07-24 | 2017-08-04 | 16832 |
| GD-AMLODIPINE/ATORVASTATIN | 10MG 80MG | TABLET | Resolved | 2020-01-22 | 2020-04-22 | 103957 |
| GD-ELETRIPTAN | 40MG | TABLET | Resolved | 2020-11-17 | 2021-02-04 | 128484 |
| GD-ELETRIPTAN | 20MG | TABLET | Resolved | 2020-12-16 | 2021-01-12 | 130219 |
| GD-ELETRIPTAN | 40MG | TABLET | Resolved | 2020-08-04 | 2020-09-22 | 121654 |
| GD-LATANOPROST | 50MCG | SOLUTION | Resolved | 2022-03-15 | 2022-03-30 | 156728 |
| GD-LATANOPROST/TIMOLOL | 50MCG 5MG | SOLUTION | Resolved | 2023-01-17 | 2023-05-25 | 181289 |
| GD-LATANOPROST/TIMOLOL | 50MCG 5MG | SOLUTION | Resolved | 2022-11-29 | 2023-01-17 | 176221 |
| GD-LATANOPROST/TIMOLOL | 5MG 50MCG | SOLUTION | Resolved | 2019-08-20 | 2019-09-18 | 91964 |
| GEN-CLOZAPINE | 200MG | TABLET | Resolved | 2017-03-23 | 2017-11-15 | 4063 |
| GEN-CLOZAPINE | 50MG | TABLET | Resolved | 2017-10-10 | 2017-10-21 | 24836 |
| GEN-CLOZAPINE | 100MG | TABLET | Avoided shortage | 2017-11-03 | 2017-11-23 | 28038 |
| INDAYO | 0.15MG 0.03MG | TABLET | Resolved | 2021-01-05 | 2021-01-21 | 130872 |
| INDAYO | 0.03MG 0.15MG | TABLET | Resolved | 2017-10-26 | 2018-08-23 | 27093 |
| INDAYO | 0.03MG 0.15MG | TABLET | Resolved | 2023-01-17 | 2023-02-02 | 181311 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-SIMVASTATIN | 5MG | TABLET | Discontinued | 2019-09-17 | 2019-09-18 | 94112 |
| MYLAN-SIMVASTATIN | 10MG | TABLET | Discontinued | 2019-09-17 | 2019-09-18 | 94117 |
| MYLAN-SIMVASTATIN | 20MG | TABLET | Discontinued | 2019-09-17 | 2019-09-18 | 94122 |
| MYLAN-SIMVASTATIN | 40MG | TABLET | Discontinued | 2019-09-17 | 2019-09-18 | 94127 |
| MYLAN-SIMVASTATIN | 80MG | TABLET | Discontinued | 2019-09-17 | 2019-09-18 | 94132 |
| MYLAN-TELMISARTAN | 40MG | TABLET | Discontinued | 2018-06-06 | 2018-08-11 | 51618 |
| MYLAN-TELMISARTAN | 80MG | TABLET | Discontinued | 2018-06-06 | 2018-08-11 | 51624 |
| MYLAN-TELMISARTAN HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6814 |
| MYLAN-TELMISARTAN HCTZ | 25MG 80MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6819 |
| MYLAN-TOLTERODINE ER | 4MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2022-02-15 | 2022-02-15 | 155040 |
| MYLAN-TOLTERODINE ER | 2MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2022-02-15 | 2022-02-15 | 155037 |
| MYLAN-TRAMADOL/ACET | 37.5MG 325MG | TABLET | Discontinued | 2017-04-13 | 2018-02-15 | 6822 |
| MYLAN-VALSARTAN | 40MG | TABLET | Discontinued | 2017-08-24 | 2018-07-04 | 20209 |
| MYLAN-VALSARTAN | 320MG | TABLET | Discontinued | 2017-08-24 | 2018-07-04 | 20217 |
| MYLAN-VALSARTAN | 160MG | TABLET | Discontinued | 2017-08-24 | 2017-11-02 | 20284 |
| MYLAN-VALSARTAN | 80MG | TABLET | Discontinued | 2018-04-04 | 2018-07-04 | 44919 |
| MYLAN-VALSARTAN HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6827 |
| MYLAN-VALSARTAN HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6833 |
| MYLAN-VALSARTAN HCTZ | 25MG 160MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6836 |
| MYLAN-VALSARTAN HCTZ | 12.5MG 320MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6841 |